Document Detail


Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study.
MedLine Citation:
PMID:  7485045     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of estrogen replacement therapy (ERT) on 3-year changes in carotid intimal-medial thickness (IMT) was explored using serial B-mode ultrasound measurements collected during 1989-1993 as part of the Asymptomatic Carotid Atherosclerotic Progression Study (ACAPS). Eligibility included increased IMT and elevated low density lipoprotein cholesterol. Of the 186 postmenopausal ACAPS women randomly assigned to receive either placebo or lovastatin, 34% reported use of ERT. Users tended to be younger than nonusers by an average of 3 years, to have more favorable high and low density lipoprotein cholesterol levels, and to be more likely to have had hysterectomies. Baseline blood pressure, body mass index, and cross-sectional IMT were similar among ERT users and nonusers. In the placebo group, IMT tended to progress among ERT nonusers but to regress among ERT users: Mean covariate-adjusted progression rates were 0.015 +/- 0.007 mm/year versus -0.012 +/- 0.012 mm/year, respectively (p = 0.05). This difference appeared to be independent of lipoprotein concentrations. Lovastatin was associated with an approximately 25% lowering of low density lipoprotein cholesterol among both ERT users and nonusers and had a marked impact on IMT progression (p = 0.004) in these women. ERT appeared to have little additional effect on IMT in women assigned to lovastatin. ERT may reduce or halt the progression of early atherosclerosis in women not receiving active lipid-lowering medication.
Authors:
M A Espeland; W Applegate; C D Furberg; D Lefkowitz; L Rice; D Hunninghake
Related Documents :
11988625 - Carotid intima-media thickness is associated with allelic variants of stromelysin-1, in...
18848325 - Clinical and subclinical cardiovascular disease and kidney function decline in the elde...
12690225 - Sex differences in carotid endarterectomy outcomes: results from the ontario carotid en...
19762025 - The role of carotid intima-media thickness assessment in cardiovascular risk evaluation...
16327945 - The ankle-brachial index is not related to mortality in elderly subjects living in nurs...
20809235 - The omega-3 index: clinical utility for therapeutic intervention.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American journal of epidemiology     Volume:  142     ISSN:  0002-9262     ISO Abbreviation:  Am. J. Epidemiol.     Publication Date:  1995 Nov 
Date Detail:
Created Date:  1995-12-14     Completed Date:  1995-12-14     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7910653     Medline TA:  Am J Epidemiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1011-9     Citation Subset:  IM    
Affiliation:
Department of Public Health Sciences, Bowman Gray School of Medicine, Winston-Salem, NC 27157-1063, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Anticholesteremic Agents / therapeutic use*
Arteriosclerosis / prevention & control*,  ultrasonography
Carotid Artery Diseases / prevention & control*,  ultrasonography
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Estrogen Replacement Therapy*
Female
Humans
Lovastatin / therapeutic use*
Middle Aged
Grant Support
ID/Acronym/Agency:
M01-RR-02802/RR/NCRR NIH HHS; R01-HL-38194/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Anticholesteremic Agents; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 75330-75-5/Lovastatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Jejunal diverticulitis manifesting with abdominal wall abscess.
Next Document:  Blood pressure reactivity to stress varies by hypertensive status and sex in Nigerians.